Highbridge Capital Management LLC Matinas Bio Pharma Holdings, Inc. Transaction History
Highbridge Capital Management LLC
- $466 Million
- Q2 2024
A detailed history of Highbridge Capital Management LLC transactions in Matinas Bio Pharma Holdings, Inc. stock. As of the latest transaction made, Highbridge Capital Management LLC holds 10,644,331 shares of MTNB stock, worth $40.9 Million. This represents 0.37% of its overall portfolio holdings.
Number of Shares
10,644,331Holding current value
$40.9 Million% of portfolio
0.37%Shares
1 transactions
Others Institutions Holding MTNB
# of Institutions
49Shares Held
39MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA9.32MShares$35.8 Million0.0% of portfolio
-
Sargent Investment Group, LLC3.49MShares$13.4 Million0.12% of portfolio
-
Black Rock Inc. New York, NY2.48MShares$9.53 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.29MShares$8.8 Million0.0% of portfolio
-
Towercrest Capital Management Newtown, PA1.89MShares$7.24 Million0.05% of portfolio
About Matinas BioPharma Holdings, Inc.
- Ticker MTNB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,864,992
- Market Cap $833M
- Description
- Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...